These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 26268736)
1. Long-term effects of the multidisciplinary risk assessment and management program for patients with diabetes mellitus (RAMP-DM): a population-based cohort study. Jiao F; Fung CS; Wan YF; McGhee SM; Wong CK; Dai D; Kwok R; Lam CL Cardiovasc Diabetol; 2015 Aug; 14():105. PubMed ID: 26268736 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) for diabetic microvascular complications: A population-based cohort study. Jiao F; Fung CS; Wan YF; McGhee SM; Wong CK; Dai D; Kwok R; Lam CL Diabetes Metab; 2016 Dec; 42(6):424-432. PubMed ID: 27568125 [TBL] [Abstract][Full Text] [Related]
3. Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses-A Population-Based and Propensity-Matched Cohort Study. Wan EYF; Fung CSC; Jiao FF; Yu EYT; Chin WY; Fong DYT; Wong CKH; Chan AKC; Chan KHY; Kwok RLP; Lam CLK Diabetes Care; 2018 Jan; 41(1):49-59. PubMed ID: 29138274 [TBL] [Abstract][Full Text] [Related]
4. Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study. Jiao FF; Fung CS; Wong CK; Wan YF; Dai D; Kwok R; Lam CL Cardiovasc Diabetol; 2014 Aug; 13():127. PubMed ID: 25142791 [TBL] [Abstract][Full Text] [Related]
5. Ten-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Macrovascular and Microvascular Complications and All-Cause Mortality: A Population-Based Cohort Study. Tang EHM; Mak IL; Tse ETY; Wan EYF; Yu EYT; Chen JY; Chin WY; Chao DVK; Tsui WWS; Ha TKH; Wong CKH; Lam CLK Diabetes Care; 2022 Dec; 45(12):2871-2882. PubMed ID: 35972235 [TBL] [Abstract][Full Text] [Related]
6. Patient Empowerment Programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study. Wong CK; Wong WC; Wan YF; Chan AK; Chung KL; Chan FW; Lam CL Diabetes Obes Metab; 2015 Feb; 17(2):128-35. PubMed ID: 25251664 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of a primary care multidisciplinary Risk Assessment and Management Program for patients with diabetes mellitus (RAMP-DM) over lifetime. Jiao F; Wan EYF; Fung CSC; Chan AKC; McGhee SM; Kwok RLP; Lam CLK Endocrine; 2019 Feb; 63(2):259-269. PubMed ID: 30155847 [TBL] [Abstract][Full Text] [Related]
8. Five-Year Cost-effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM). Jiao FF; Fung CSC; Wan EYF; Chan AKC; McGhee SM; Kwok RLP; Lam CLK Diabetes Care; 2018 Feb; 41(2):250-257. PubMed ID: 29246949 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial. Dauriz M; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP; J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679559 [TBL] [Abstract][Full Text] [Related]
10. Risk of Dementia Among Patients With Diabetes in a Multidisciplinary, Primary Care Management Program. Wang K; Zhao S; Lee EK; Yau SZ; Wu Y; Hung CT; Yeoh EK JAMA Netw Open; 2024 Feb; 7(2):e2355733. PubMed ID: 38345817 [TBL] [Abstract][Full Text] [Related]
11. Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study. Fung CSC; Wan EYF; Chan AKC; Lam CLK BMC Cardiovasc Disord; 2017 Jun; 17(1):166. PubMed ID: 28645252 [TBL] [Abstract][Full Text] [Related]
13. Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study. Echouffo-Tcheugui JB; Zhao S; Brock G; Matsouaka RA; Kline D; Joseph JJ Diabetes Care; 2019 Mar; 42(3):486-493. PubMed ID: 30659073 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a prevention program in the incidence of cardiovascular outcomes in a low-income population from Colombia: a real-world propensity score-matched cohort study. Miranda-Machado P; Salcedo-Mejía F; Parra-Padilla D; Vargas-Moranth R; Alvis-Zakzuk NR; Paz-Wilches J; Fernández-Mercado J; De la-Hoz Restrepo F; Alvis-Guzmán N BMC Public Health; 2020 Sep; 20(1):1416. PubMed ID: 32943016 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk in mild to moderately decreased glomerular filtration rate, diabetes and coronary heart disease in a southern European region. Gil-Terrón N; Cerain-Herrero MJ; Subirana I; Rodríguez-Latre LM; Cunillera-Puértolas O; Mestre-Ferrer J; Grau M; Dégano IR; Elosua R; Marrugat J; Ramos R; Baena-Díez JM; Salvador-González B Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):212-218. PubMed ID: 30709697 [TBL] [Abstract][Full Text] [Related]
16. Assessment of Hypertension Complications and Health Service Use 5 Years After Implementation of a Multicomponent Intervention. Yu EYT; Wan EYF; Mak IL; Chao DVK; Ko WWK; Leung M; Li YC; Liang J; Luk W; Wong MMY; Ha TKH; Chan AKC; Fong DYT; Lam CLK JAMA Netw Open; 2023 May; 6(5):e2315064. PubMed ID: 37223900 [TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting. Thukkani AK; Agrawal K; Prince L; Smoot KJ; Dufour AB; Cho K; Gagnon DR; Sokolovskaya G; Ly S; Temiyasathit S; Faxon DP; Gaziano JM; Kinlay S J Am Coll Cardiol; 2015 Sep; 66(10):1091-101. PubMed ID: 26337986 [TBL] [Abstract][Full Text] [Related]
18. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus. Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209 [TBL] [Abstract][Full Text] [Related]
19. Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus. Lee CH; Woo YC; Chow WS; Cheung CYY; Fong CHY; Yuen MMA; Xu A; Tse HF; Lam KSL J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588089 [TBL] [Abstract][Full Text] [Related]
20. Benefits of Cardiac Rehabilitation on Cardiovascular Outcomes in Patients With Diabetes Mellitus After Percutaneous Coronary Intervention. Jiménez-Navarro MF; Lopez-Jimenez F; Pérez-Belmonte LM; Lennon RJ; Diaz-Melean C; Rodriguez-Escudero JP; Goel K; Crusan D; Prasad A; Squires RW; Thomas RJ J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29021270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]